Disclaimer

etretinate-oral, Tegison

GENERIC NAME: ETRETINATE - ORAL (eh-TRET-in-ate)

BRAND NAME(S): Tegison

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: Because etretinate has caused serious birth defects, do not use this medicine if you are pregnant or plan to become pregnant. After stopping treatment, the amount of time to pass before you may safely become pregnant has not been determined. Consult your doctor about this. Females who are able to have children must not use this medication unless they have a negative pregnancy test 2 weeks before starting this drug; will start therapy only on the 2nd or 3rd day of next normal menstrual period; use reliable methods of birth control at least 1 month before using etretinate, while using etretinate, and for an extended period of time after stopping this medication; are counseled about the dangers of using this medication while pregnant. Etretinate use has been linked to liver problems (hepatitis) and increased fluid pressure on the brain (pseudotumor cerebri). Notify your doctor immediately if you develop any of these symptoms: yellowing eyes or skin, dark urine, stomach pain, unusual fatigue, headache, nausea and vomiting, or vision changes. Your doctor will decide whether to continue using etretinate.




Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright

STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!